Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 Jun 19;182(3):665–677. doi: 10.1007/s10549-020-05714-2

Table 1-. Decreasing plasma AF threshold does not improve concordance with tumor samples.

Concordant mutations were assessed at plasma thresholds of ≥5% and ≥1% AF to determine how lower plasma AF thresholds affected concordance with tumor mutations.

Patient Plasma Calls at ≥5% AF Plasma Calls at ≥1% AF Concordant Mutations Gained
2 87 88 0
8 137 139 0
9 48 486 0
9A 122 1068 0
10 247 3477 0